The Royal Swedish Academy of Sciences awarded the 2026 Nobel Prize in Chemistry to Henri B. Kagan of Université Paris-Sud, France, and Kenso Soai of Tokyo University of Science, Japan, for their discovery of non-linear effects and autocatalysis in asymmetric organic synthesis. The announcement was made on October 7, 2026, recognizing their work on chemical asymmetry and homochirality in molecules.
Kagan and Soai’s research solved a longstanding mystery in chemistry: how homochirality, the preference for one mirror image variant of molecules such as amino acids, emerges in nature. Their experiments demonstrated how chemical reactions can favor one mirror image over the other through autocatalysis and non-linear effects, enabling the production of molecules that interact selectively with living organisms, a breakthrough detailed in the Nobel Prize press release from nobelprize.org.
This discovery has significant implications for organic synthesis and the pharmaceutical industry, where producing a single mirror image of a molecule is crucial for drug effectiveness and safety. Their work advances understanding of molecular chirality, a fundamental property in biochemistry, and provides a framework for designing asymmetric synthesis processes. The prize highlights the importance of this field, which bridges chemistry and biology.
The Nobel Prize in Chemistry 2026 was officially announced on October 7, 2026, by the Royal Swedish Academy of Sciences, marking a milestone in the study of molecular asymmetry and its applications in science and medicine.